<?xml version="1.0" encoding="UTF-8"?>
<p> The only effective way to combat the growing threat of orthopoxvirus infections of humans is vaccination [
 <xref rid="R1" ref-type="bibr">1</xref>, 
 <xref rid="R3" ref-type="bibr">3</xref>]. However, the accumulation of immunodeficiency states (HIV infection; patients after organ transplantation; cancer patients, etc.) in recent decades has led to a situation in which mass vaccination of populations with the classic live VACV vaccine is now contraindicated. Therefore, there is an urgent need to develop modern live vaccines that can be much safer compared to the classic smallpox vaccine [
 <xref rid="R36" ref-type="bibr">36</xref>, 
 <xref rid="R37" ref-type="bibr">37</xref>]. 
</p>
